insights_auto
Why is VSTM down 3.12%?
Dive Deeperchevron_right
VSTM:NASDAQ
Verastem Inc
$7.75
arrow_downward
-3.12%(-0.25) 1D
$7.86
arrow_upward
+1.42% (+0.11)bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VSTM...
Open
$8.08
High
$8.18
Low
$7.70
Mkt. cap
675.55M
Avg. vol.
2.26M
Volume
13.00
52-wk high
$10.82
52-wk low
$3.43
EPS
-$2.46
Beta
0.39
Shares outstanding
90.56M
No. of employees
102
Open
$8.08
High
$8.18
Low
$7.70
Mkt. cap
675.55M
Avg. vol.
2.26M
Volume
13.00
52-wk high
$10.82
52-wk low
$3.43
EPS
-$2.46
Beta
0.39
Shares outstanding
90.56M
No. of employees
102
News stories
From web sources and news partners
Stock Traders Daily
·
4 hours ago
Trading Systems Reacting to (VSTM) Volatility
AD HOC NEWS
·
8 hours ago
BTIG keeps its Buy rating for Verastem stock
Simply Wall Street
·
1 day ago
This Insider Has Just Sold Shares In Verastem
Profile
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
About Verastem Inc
CEOBrian Stuglik
Employees102
Founded2010
HeadquartersNeedham, Massachusetts, United States
SectorBiotechnology
Websiteverastem.com